Discontinued — last reported Q3 '22
Net product sales — Net Sales
United Therapeutics Net product sales — Net Sales increased by 10.5% to $516.00M in Q3 2022 compared to the prior quarter. Year-over-year, this metric grew by 16.0%, from $444.70M to $516.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing market demand, successful commercial execution, or effective pricing strategies, while a decrease may signal competitive pressure, patent expirations, or declining patient adherence.
Detailed definition
This metric represents the total revenue generated from the sale of pharmaceutical products after accounting for returns...
Peer comparison
This is a standard revenue reporting metric across the biopharmaceutical industry, comparable to 'Net Product Revenue' or 'Net Sales' reported by peers in the specialty drug and rare disease sectors.
uthr_segment_net_product_sales_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | |
|---|---|---|---|---|---|
| Value | $446.50M | $444.70M | $451.90M | $466.90M | $516.00M |
| QoQ Change | — | -0.4% | +1.6% | +3.3% | +10.5% |
| YoY Change | — | — | — | +4.6% | +16.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is United Therapeutics's net product sales — net sales?
- United Therapeutics (UTHR) reported net product sales — net sales of $516.00M in Q3 2022.
- How has United Therapeutics's net product sales — net sales changed year-over-year?
- United Therapeutics's net product sales — net sales increased by 16.0% year-over-year, from $444.70M to $516.00M.
- What does net product sales — net sales mean?
- The total revenue earned from selling pharmaceutical products after subtracting discounts and returns.